Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Canada Clear all

173 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20024
20032
20046
200510
20068
20076
200810
20099
201011
201110
20129
201310
20146
20157
20166
20177
20184
20197
20206
20214
20222
20234
20245
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107
Terminated27
Recruiting17
Active, not recruiting12
Unknown status8
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche12
Pfizer10
AHS Cancer Control Alberta8
GlaxoSmithKline7
Alliance for Clinical Trials in Oncology6
AstraZeneca6
NSABP Foundation Inc6
National Cancer Institute (NCI)6
Novartis Pharmaceuticals6
Ottawa Hospital Research Institute6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms173
Neoplasm Metastasis15
Triple Negative Breast Neoplasms10
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms8
Head and Neck Neoplasms7
Neoplasms7
Ovarian Neoplasms7
Brain Neoplasms6
Sarcoma5

Trials

Showing 1 to 25 of 173. Each trial links to its page on Pharma Observatory.

73 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.